Loading the section
The price of Praxis Precision Medicines, Inc. (PRAX) on October 9, 2026 is 259.86 USD, -1.40% on the day. Over 52 weeks the stock traded between 50.56 USD and 392.70 USD; the price now sits 61% of the way up that range. Over the past year the price changed by +378.65%. Market capitalization is 7.37 billion USD, rank 30 among 374 stocks of the same industry with a known capitalization.
Closing prices for 09 October 2026
Next earnings report: 04 November 2026 · Earnings calendar
Praxis Precision Medicines, Inc. trades on Nasdaq under the ticker PRAX. The company belongs to the Health care sector. The trading history on this page starts on 16 October 2020.
Over the past 52 weeks PRAX has traded between 50.56 $ and 392.70 $. As of 09 October 2026 the price stood 61.17 % of the way from the 52-week low to the high.
Over one year PRAX shares rose 378.65 %; over six months they fell 17.80 %. Volatility over 90 days is 58.58 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 5.2, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 266.91 | 267.56 | 259.00 | 259.86 | 517,225 |
| 08 October 2026 | 273.74 | 273.96 | 260.07 | 263.55 | 675,600 |
| 07 October 2026 | 277.16 | 285.63 | 271.28 | 278.02 | 444,200 |
| 06 October 2026 | 289.47 | 289.47 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Praxis Precision Medicines, Inc. (PRAX) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 0 $, net income was -303.3m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:99 HIGH STREET, 30TH FLOOR, BOSTON, MA, 02110, US
Praxis Precision Medicines, Inc. reported revenue of 0 $ and a net loss of 327M $ over the last four quarters. Revenue changed by −100.00 % year over year. Earnings per share are −13.39 $. Market capitalisation is 7.4B $.
PRAX has a return on equity of −23.16 %, above the sector median of −41.68 %. Return on assets is −22.36 %, above the sector median of −32.11 %.
| 1.2B |
| PFEPfizer, Inc. | 28.18 | +1.28 % | 929M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 272.17 |
| 280.14 |
| 435,200 |
| 05 October 2026 | 299.12 | 299.12 | 278.01 | 283.56 | 511,100 |
| 02 October 2026 | 290.13 | 298.56 | 286.00 | 295.51 | 456,100 |
| 01 October 2026 | 287.83 | 292.47 | 282.00 | 286.91 | 381,600 |
| 30 September 2026 | 284.65 | 296.27 | 282.00 | 291.23 | 710,600 |
| 29 September 2026 | 283.28 | 289.16 | 278.39 | 281.00 | 349,600 |
| 28 September 2026 | 280.78 | 292.18 | 277.91 | 285.65 | 436,700 |
| 25 September 2026 | 284.45 | 289.05 | 278.60 | 280.78 | 462,200 |
| 24 September 2026 | 281.18 | 286.38 | 276.34 | 281.79 | 535,400 |
| 23 September 2026 | 301.37 | 304.94 | 275.89 | 282.12 | 1M |
| 22 September 2026 | 300.19 | 312.46 | 298.40 | 300.65 | 570,200 |
| 21 September 2026 | 301.69 | 305.79 | 295.22 | 298.87 | 543,800 |
| 18 September 2026 | 312.76 | 314.01 | 295.71 | 298.95 | 829,800 |
| 17 September 2026 | 313.65 | 318.00 | 306.50 | 310.47 | 555,900 |
| 16 September 2026 | 315.22 | 321.95 | 303.88 | 308.99 | 541,900 |
| 15 September 2026 | 330.42 | 333.06 | 311.98 | 312.90 | 205,700 |
| 14 September 2026 | 337.67 | 341.71 | 328.95 | 330.55 | 375,600 |